Form D · Pharmaceuticals
Aro Biotherapeutics Co
Philadelphia, PA · CIK 0001773305
Offering snapshot reported Dec 28, 2022 · SEC filing
- Reported sold
- $24M Offering amount: $100M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 13, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 28, 2022 | Initial | $24,032,627 | No comparison | 12 | SEC filing |
| Dec 16, 2021 | Amendment | $90,337,478 | $48,000,017vs Jan 5, 2021 | 14 | SEC filing |
| Jun 11, 2021 | Amendment | $64,337,469 | $22,000,008vs Jan 5, 2021 | 14 | SEC filing |
| Apr 16, 2021 | Amendment | $44,837,460 | $2,499,999vs Jan 5, 2021 | 14 | SEC filing |
| Jan 5, 2021 | Initial | $42,337,461 | No comparison | 13 | SEC filing |
| Jan 6, 2020 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Apr 15, 2019 | Initial | $3,500,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-468913
Source: Form D, filed Dec 28, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Elizabeth Anderson | Director |
| Susan B Dillon | Director, Executive |
| Mittie Doyle | Executive |
| Saan Chirag Gandhi | Director |
| Scott Greenberg | Executive |
| Daniel Janse | Director |
| Mark Laurenzi | Executive |
| Jess Lifton | Director |
| Christopher Mirabelli | Director |
| Karyn O'neil | Director, Executive |
| Bruce Peacock | Director |
| Kevin Raidy | Director |
| Marten Steen | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
601 Walnut Street Suite 740
Philadelphia, PA, 19106
Philadelphia, PA, 19106